SCHEMBL13359291

SCHEMBL13359291

Cc1ccc(C(C)(C)C)cc1NC(=O)c1cc2cccc([N+](=O)[O-])c2s1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 6/20 0.51
▸ RAB9A P51151 4/20 0.51
▸ HTT P42858 4/20 0.51
▸ NPC1 O15118 3/20 0.51
▸ MAPK1 P28482 3/20 0.51
▸ HPGD P15428 3/20 0.51
▸ GAA P10253 1/20 0.51
▸ ALDH1A1 P00352 3/20 0.49
▸ GLA P06280 1/20 0.49
▸ CASP3 P42574 1/20 0.49
▸ SENP8 Q96LD8 1/20 0.49
▸ SENP7 Q9BQF6 1/20 0.49
▸ SENP6 Q9GZR1 1/20 0.49
▸ LMNA P02545 4/20 0.46
▸ MAPT P10636 2/20 0.46
▸ ATM Q13315 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ L3MBTL1 Q9Y468 2/20 0.45
▸ DHPS P49366 1/20 0.42
▸ POLB P06746 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13797972 0.86 DHPS (0.47) SMN1; SMN2RAB9AHTTNPC1HPGD
SCHEMBL13359267 0.84 NPC1 (0.49) SMN1; SMN2RAB9AHTTNPC1MAPK1
SCHEMBL13359290 0.83 DHPS (0.44) RAB9AHTTNPC1HPGDALDH1A1
SCHEMBL13811161 0.81 DHPS (0.43) RAB9AHTTNPC1HPGDLMNA
SCHEMBL13797936 0.78 MAPK14 (0.68) SMN1; SMN2RAB9AHTTNPC1MAPK1
SCHEMBL13359286 0.78 MAPK14 (0.49) SMN1; SMN2RAB9AHTTNPC1MAPK1
SCHEMBL13359266 0.78 MAPK14 (0.59) RAB9AHTTHPGDCASP3SENP8
SCHEMBL13359225 0.75 HTT (0.52) RAB9AHTTNPC1HPGDGAA
SCHEMBL2893152 0.75 ALDH1A1 (0.49) SMN1; SMN2MAPK1HPGDALDH1A1LMNA
SCHEMBL13797975 0.74 MAPK14 (0.55) SMN1; SMN2RAB9AHTTHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1497278-B1 HETEROCYCLIC AMIDE DERIVATIVES AS CYTOKINE INHIBITORS BOEHRINGER INGELHEIM PHARMA (US) 2010-05-26 — — EP disclosed
Send feedback